Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment
- PMID: 25633674
- DOI: 10.3233/JAD-141947
Olfactory cortex degeneration in Alzheimer's disease and mild cognitive impairment
Abstract
Background: Olfactory deficits are prevalent in patients with Alzheimer's disease (AD) and mild cognitive impairment (MCI). These symptoms precede clinical onset of cognitive and memory deficits and coincide with AD pathology preferentially in the central olfactory structures, suggesting a potential biomarker for AD early detection and progression.
Objective: Therefore, we tested the hypothesis that structural degeneration of the primary olfactory cortex (POC) could be detected in AD as well as in MCI patients and would be correlated with olfactory functional magnetic resonance imaging (fMRI) alterations, reflecting loss of olfactory cortex activity.
Methods: Total structural volumes and fMRI activation volumes of the POC and hippocampus were measured along with olfactory and cognitive behavioral tests in 27 cognitively normal (CN), 21 MCI, and 15 AD subjects.
Results: Prominent atrophy in the POC and hippocampus was found in both AD and MCI subjects and correlated with behavioral measurements. While behavioral and volumetric measurements showed a gradual decline from CN to MCI to AD, olfactory activation volume in the POC and hippocampus showed a steeper decline in the MCI group compared to corresponding tissue volume, resembling the AD group.
Conclusions: Decline in olfactory activity was correlated with the AD structural degeneration in the POC. A more prominent olfactory activity deficit than that of behavioral and tissue volume measurements was shown in the MCI stage. Olfactory fMRI may thus provide an earlier and more sensitive measure of functional neurodegeneration in AD and MCI patients.
Keywords: Alzheimer's disease; MRI; functional MRI; mild cognitive impairment; olfaction.
Similar articles
-
Central Olfactory Dysfunction in Alzheimer's Disease and Mild Cognitive Impairment: A Functional MRI Study.J Alzheimers Dis. 2017;59(1):359-368. doi: 10.3233/JAD-170310. J Alzheimers Dis. 2017. PMID: 28671131
-
Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.J Neurol Sci. 2015 Aug 15;355(1-2):174-9. doi: 10.1016/j.jns.2015.06.013. Epub 2015 Jun 10. J Neurol Sci. 2015. PMID: 26076880
-
White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.Neurobiol Aging. 2015 Sep;36(9):2447-57. doi: 10.1016/j.neurobiolaging.2015.05.011. Epub 2015 May 28. Neurobiol Aging. 2015. PMID: 26095760 Free PMC article.
-
Olfactory function in mild cognitive impairment and Alzheimer's disease: A meta-analysis.Laryngoscope. 2019 Feb;129(2):362-369. doi: 10.1002/lary.27399. Epub 2018 Nov 22. Laryngoscope. 2019. PMID: 30565695 Review.
-
Olfactory neuropathology in Alzheimer's disease: a sign of ongoing neurodegeneration.BMB Rep. 2021 Jun;54(6):295-304. doi: 10.5483/BMBRep.2021.54.6.055. BMB Rep. 2021. PMID: 34162463 Free PMC article. Review.
Cited by
-
Fast Multi-Task SCCA Learning with Feature Selection for Multi-Modal Brain Imaging Genetics.Proceedings (IEEE Int Conf Bioinformatics Biomed). 2018 Dec;2018:356-361. doi: 10.1109/BIBM.2018.8621298. Epub 2019 Jan 24. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2018. PMID: 30881731 Free PMC article.
-
Comparison of odor identification among amnestic and non-amnestic mild cognitive impairment, subjective cognitive decline, and early Alzheimer's dementia.Neurol Sci. 2018 Mar;39(3):557-564. doi: 10.1007/s10072-018-3261-1. Epub 2018 Jan 30. Neurol Sci. 2018. PMID: 29383614
-
Odor Identification and Regional Gray Matter Atrophy in Patients with Alzheimer's Disease, Parkinson's Disease, and the Healthy Elderly: A Cross-Sectional Structural MRI Study.Brain Sci. 2021 Sep 29;11(10):1296. doi: 10.3390/brainsci11101296. Brain Sci. 2021. PMID: 34679361 Free PMC article.
-
Identifying vulnerable brain networks associated with Alzheimer's disease risk.Cereb Cortex. 2023 Apr 25;33(9):5307-5322. doi: 10.1093/cercor/bhac419. Cereb Cortex. 2023. PMID: 36320163 Free PMC article.
-
Dysfunctional Sensory Modalities, Locus Coeruleus, and Basal Forebrain: Early Determinants that Promote Neuropathogenesis of Cognitive and Memory Decline and Alzheimer's Disease.Neurotox Res. 2016 Oct;30(3):295-337. doi: 10.1007/s12640-016-9643-3. Epub 2016 Jun 23. Neurotox Res. 2016. PMID: 27339162 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical